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Trypanosoma cruzi, the etiological agent of Chagas disease exhibits multiple
mechanisms to guarantee its establishment and persistence in the infected host. It
has been well demonstrated that T. cruzi is not able to synthesize sialic acids (Sia). To
acquire the monosaccharide, the parasite makes use of a multifunctional enzyme called
trans-sialidase (Tc-TS). Since this enzyme has no analogous in the vertebrate host, it
has been used as a target in drug therapy development. Tc-TS preferentially catalyzes
the transfer of Sia from the host glycoconjugates to the terminal β-galactopyranosyl
residues of mucin-like molecules present on the parasite’s cell surface. Alternatively,
the enzyme can sialylate/re-sialylate glycoconjugates expressed on the surface of host
cells. Since its discovery, several studies have shown that T. cruzi employs the Tc-TS
activity to modulate the host cell sialoglycophenotype, thus favoring its perpetuation
in the infected vertebrate. In this review, we summarize the dynamic of host/parasite
sialoglycophenotype modulation, highlighting its role in the subversion of host immune
response in order to promote the establishment of persistent chronic infection.
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THE IMPORTANCE OF SIALO-CONTAINING GLYCANS IN CELL
BIOLOGY
All living cells possess a complex and dense coating composed of glycoconjugates (Varki, 1993).
Such structures exist as glycolipids, glycoproteins, and proteoglycans. Among other functions,
cell surface glycans mediate cell–cell recognition and control interactions between cells and
other components in their local environment. Throughout evolution, glycans were designated
several roles based on their physical features and structural diversity (Varki, 2011). Advances in
glycobiology researches have provided the means to correlate glycan structures to physiological and
pathological conditions (Lowe and Marth, 2003; Baum et al., 2014; Schmaus et al., 2014; Kato and
Ishiwa, 2015; Stowell et al., 2015). The result is that glycoscience is emerging as a major contributor
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to the understanding of biology and medicine. The functional
specificity of glycans is often dictated by the monosaccharides at
the outermost ends of glycan chains (Berger et al., 1982; Varki,
1993; Hart, 2013). In mammals, the glycan chain of glycoproteins
and glycolipids often end with sialic acids (Sia), a group of
sugars with distinctive chemical properties that determine their
functions (Traving and Schauer, 1998). Discovered about 70 years
ago, Sia is a generic term referring to nine-carbon alpha (α)-keto
sugars with a carboxyl group linked directly to the ring as
well as its N or O substituted derivatives. There are over
50 Sia described, while the two most commonly found in
mammals are N-acetyl and N-glycolyl neuraminic acid (Varki
and Schauer, 2009). It is estimated that a cell exhibits tens of
millions Sia molecules, with the concentration in the glycocalyx
approaching 100 mM (Varki and Gagneux, 2012). Thanks to
its bulky size and the electron density of the carboxyl group,
Sia provides an important source of negative charge, which
could alter the biophysical properties of cellular interactions. In
eukaryotic cells, Sia residues are responsible for mediating many
important interactions, including but not limited to regulation of
transmembrane receptor function, altering membrane transport,
control of glycoproteins (and even cell) half-life (Schauer,
2000). One of the most notable functions of Sia is to regulate
immune response, playing an important role in self and non-
self recognition (Traving and Schauer, 1998). It should not come
as a surprise that several pathogenic microorganisms, such as
viruses, bacteria, and protozoa have evolved strategies to exploit
this feature (Neu et al., 2011; Nishikawa et al., 2013; Chang and
Nizet, 2014). One of the more stylish mechanisms of cell surface
sialylation is exploited by the protozoal Trypanosoma cruzi, the
etiological agent of Chagas disease (Previato et al., 1985; Zingales
et al., 1987; Schenkman et al., 1991, 1992; Mucci et al., 2006; Muia
et al., 2010).
Trypanosoma cruzi trans-SIALIDASE
AND HOST CELL INVASION
Incapable of synthetizing Sia, T. cruzi has developed an elegant
mechanism to take advantage of the Sia residues displayed in
its mammalian host sialoglycans in order to avoid detection and
elimination by immune cells (Pereira-Chioccola and Schenkman,
1999; Dc-Rubin and Schenkman, 2012; Freire-de-Lima et al.,
2015). Since it was shown that T. cruzi could not use the
activated monosaccharide precursor CMP-Neu5Ac, as it was
first considered (Schauer et al., 1983), it was proposed a novel
metabolic mechanism of trans-glycosylation, by which T. cruzi
would incorporate Sia onto its own cell surface (Previato et al.,
1985). Incorporation of Sia on the surface molecules of T. cruzi
parasite is catalyzed by the enzyme called trans-sialidase (Tc-TS)
Previato et al., 1985; Schenkman et al., 1991). It was demonstrated
in vitro and in vivo (Zingales et al., 1987; Previato et al., 1990) the
activity of Tc-TS was characterized as specific for α-2,3 Sia, being
responsible for the transfer of Sia residues from the mammal host
surface sialylated molecules to the parasite mucin-like acceptors
(Schenkman et al., 1991; Parodi et al., 1992; Ruiz Rde et al., 1993;
Previato et al., 1994).
In T. cruzi, the relevance of the acquisition of Sia is not
completely known. However, there are proposals that such an
event might help trypomastigote forms adhere and penetrate
into non-phagocytic cells (Ming et al., 1993; Schenkman et al.,
1993). Sia also provides a strong negatively charged cover
that protects parasites against human lytic antibodies specific
for α-galactosyl residues present on the trypomastigote surface
(Pereira-Chioccola et al., 2000).
The transfer of a Sia residue onto an acceptor hinders the
access of a second residue when two potential acceptor sites are
present on the same oligosaccharide (Previato et al., 1995). Tc-TS
can also operate as a viral and bacterial sialidase, irreversibly
transferring Sia to water in the absence of a carbohydrate acceptor
(Vandekerckhove et al., 1992). Analysis of the crystal structure
revealed that the molecular architecture of the Tc-TS active site
preserves numerous conserved features of microbial sialidases
(Buschiazzo et al., 2002). Furthermore, all sialidases studied so far,
including Tc-TS, catalyze sialoside hydrolysis with configuration
retention (Todeschini et al., 2000).
There has been significant progress in understanding the
importance of Tc-TS on the biology of T. cruzi. However,
obstacles such as the lack of knockout strains, as well as the
absence of specific Tc-TS inhibitors pose difficulties for the
progress in the area. In regard to the Tc-TS inhibitors, many
of them are not strong enough to serve as a scaffold to the
development of drug targeting Tc-TS. In addition, most are
derivatives of the substrate Sia or a transition state analog known
as 2,3-dehydro-3-deoxy-N-acetylneuraminic acid (DANA), with
in vitro IC(50) values near the milimolar range and low in vivo
efficacy (Uemura et al., 1992; Amaya et al., 2003; Arioka et al.,
2010; Dc-Rubin and Schenkman, 2012). Recent studies suggest
that high affinity inhibitory monoclonal antibodies (mAb) for
Tc-TS might provide a rational framework for novel approaches
in the design of chemotherapeutic drugs (Buschiazzo et al.,
2012).
Over the last years, several papers described by Campetella’s
group demonstrated that active Tc-TS (aTS) induces systemic
effects during the acute phase of the disease (Mucci et al.,
2002, 2005; Tribulatti et al., 2005; Risso et al., 2007; Ruiz Díaz
et al., 2015), until the elicitation of broad neutralizing antibodies
(Pitcovsky et al., 2002). Buschiazzo et al. (2012) reported the
identification and detailed characterization of the neutralizing
mouse mAb 13G9, which was able to recognize and inhibit Tc-
TS with high specificity. The crystal structure of the complex
involving the antigen-binding fragment and the globular region
of Tc-TS demonstrated that not obstructing the enzyme’s catalytic
site, the antibody inhibited the movement of an assisting tyrosine
(Y119), which plays an important role in the trans-glycosidase
mechanism (Buschiazzo et al., 2002). The authors suggest that
such results may bring into light new strategies for chemotherapy
in Chagas disease and for disclosure of aTS function in T. cruzi
pathogenesis and biology.
Besides encoding aTS, the genes of the TS family also encode
its inactive analog (iTS). iTS has a His at position 342, while
active members contain a Tyr at the same position (Cremona
et al., 1995; Egima et al., 1996). It has been suggested that
iTS may mediate the initial contact between T. cruzi and host
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cells, functioning as an adhesin that contains two sugar-binding
distinct sites, for Sia and β-galactose (Todeschini et al., 2004).
Recently, Ruiz Díaz et al. (2015) demonstrated that both aTS
and iTS besides to induce a Th2-like phenotype in naive T cells,
also compromise the emergence of Th1 cells. Additionally, both
isoforms were associated with the parasite’s ability to reduce IL-2
production and IL-2Ra expression by T cells. The authors suggest
that TS proteins are able to manipulate the TCD4+ response
throughout their maturation stages to favor parasite survival and
infection.
The bivalent nature of iTS could promote a glycan
cross-linking believed to be essential for cellular signal
transduction. Tc-TS has essentially two different domains.
The N-terminal, which contains the catalytic domain of the
enzyme (Ribeirao et al., 1997), and the C-terminal, which is
composed basically of 12 amino acids-long units repeated in
tandem, termed SAPA (shed acute-phase antigen; Affranchino
et al., 1989), which is not required for TS activity (Campetella
et al., 1994). Tc-TS is linked to the parasite membrane via
glycosylphosphatidylinositol (GPI) anchor and shed into the
bloodstream during the infection (Schenkman et al., 1994).
Nowadays, it is well recognized that Tc-TS is an important
virulence factor involved in cell invasion and pathogenesis
of Chagas disease (Mendonça-Previato et al., 2010; Dc-Rubin
and Schenkman, 2012; Miller and Roitberg, 2013; Freire-
de-Lima et al., 2015). However, the studies regarding the
importance of Tc-TS for cell invasion and parasite survival
were paramount to understanding how T. cruzi is capable of
subverting the immune system by disturbing the host cells
sialoglycophenotype.
ROLES OF SIALIC ACIDS ON T CELL
BIOLOGY
It is well documented that in T cells, different lectin families
recognize distinct sialylated ligands on glycoproteins or
glycolipids to regulate their functions (Rabinovich et al.,
2002a,b; Ley and Kansas, 2004; Crocker et al., 2007; Crocker
and Redelinghuys, 2008). Examples include siglecs, a family
of Sia-binding lectins that belong to the superfamily of I-type
lectins (Crocker and Redelinghuys, 2008). Most siglecs bind
α-2,3 and/or α-2,6-linked Sia on penultimate Gal residues
on cell surface glycoproteins or glycolipids; however, some
members bind to repeating Sia chains (Varki and Angata,
2006). In the immune system, siglecs mainly function as
controllers of cell signaling, although roles for some siglecs
in pathogen recognition and innate immunity have been
proposed (von Gunten and Bochner, 2008). Erdmann et al.
(2009) demonstrated that sialylated ligands on T. cruzi
interact with Siglec-E (sialic acid-binding Ig-like lectin-E)
on dendritic cells (DC), and such interaction suppressed
the production of the proinflammatory cytokine IL-12 and
subsequent T cell activation. Recently, it was proposed
that sulfates from cruzipain, another important antigen
expressed by T. cruzi, might play an essential role in the
interaction with Siglec-E on inflammatory cells, favoring the
persistence of the parasite in its mammalian hosts (Ferrero et al.,
2016).
Sia plays crucial roles in the regulation of host immunity, as
evidenced by the sialylation changes sustained by naïve T cells
during thymic selection, a tightly regulated process, essential
for establishing central tolerance (Daniels et al., 2001; Moody
et al., 2001; Cao and Crocker, 2011; Paulson et al., 2012). The
alterations suffered on cell surface N- and O-linked glycans,
including glycoprotein sialylation, during T cell development and
differentiation (Daniels et al., 2002) might regulate the T cell
response through a direct effect on the intrinsic properties of
specific proteins, or by modulating the binding of a disparate
set of cell surface proteins to a specific carbohydrate moiety.
It is important to bring out that many of the changes in
the degree of sialylation of carbohydrate chains observed in T
cells during their development can be monitored with plant
lectins (Sharon, 1983; Daniels et al., 2002). It has been shown
in vitro and in vivo that T cell activation is accompanied
by loss of Sia from core 1 O-glycans (Siaα2,3Galβ1,3GalNAc-
Ser/Thr; Galvan et al., 1998; Bi and Baum, 2009), which leads
to exposure of asialo core 1 O-glycans. Such residues can be
detected with the plant lectin peanut agglutinin (PNA), that
recognizes Galβ1,3GalNAc sequences on several glycoproteins
including CD8, CD43, and CD45 (Wu et al., 1996). It is
a known fact that the loss of cell-surface Sia during T cell
activation enhances TCR reactivity with antigens (Galvan et al.,
1998; Harrington et al., 2000; Bi and Baum, 2009). Indeed,
T cell cytolytic activity may be boosted by sialidase treatment,
with a simultaneous reduction in cell surface negative charge
(Sadighi Akha et al., 2006). In addition, de-sialylated CD8+
T cells undergo more rounds of cell division following contact
with antigen (Pappu and Shrikant, 2004). Recognition and
disposal of pathogens rely upon the concerted actions of adaptive
and innate immunological mechanisms, including recruitment
of different cell types as well as production and release of
cytokines, antibodies or other effector molecules (Janeway,
2001). In regards to adaptive response, while the importance
of CD8+ T cells is well described when it comes to the
control of several viral and bacterial infections, it is seldom
mentioned that eukaryotic pathogens, such as protozoans, are
also subject to the action of cytotoxic lymphocytes. Chagas
disease is probably the most well understood example of the
role CD8+ T cells play during protozoan infections. In its
vertebrate hosts, T. cruzi is perpetually changing between its
intracellular amastigote forms and extracellular trypomastigote
ones. There is a great range of cells that are subject to
invasion by the parasite, including but not limited to fibroblasts,
macrophages, myocytes, and adipocytes. During the intracellular
stages, T. cruzi antigens are presented by antigen presenting
cells (APCs) through by MHC class I molecules, providing
many opportunities for detection by CD8+ T cells (Garg et al.,
1997). Several reports confirmed the importance of CD8+ T
cell cytotoxicity regarding Chagas disease (Tarleton, 2007, 2015;
Padilla et al., 2009; Dos Santos Virgilio et al., 2014). One
of the most important was the identification of a number
of epitopes expressed in proteins belonging to the TS family
genes (Martin et al., 2006). Until that point, there was a lack
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of immunodominant T cell epitopes, but now it is accepted
that members of the TS gene family are a good target for
CD8+ T cells. That discovery has not only led to a better
understanding of how the immune system reacts to T. cruzi
infection, but in a more practical venue has also fueled the
research on vaccine development (Machado et al., 2006; Araujo
et al., 2014; Bontempi et al., 2015). Although it is universally
accepted that CD8+ T cell response is an important factor in
mediating host survival during T. cruzi infection, there is a
substantial delay in the appearance of antigen specific CD8+ T
cells following infection (Martin et al., 2006; Tzelepis et al., 2006).
This delay differs from the quick response of CD8+ T cells in
other bacterial, viral, and, even protozoal infections (Kaech et al.,
2002), suggesting that a mechanism of immune subversion is
operative.
Trypanosoma cruzi trans-SIALIDASE
MODULATES T CELL
SIALOGLYCOPHENOTYPE
As mentioned above, Sia content of T cell glycoproteins and
glycolipids is regulated during both T cell development in the
thymus and activation in the periphery (Moody et al., 2001;
Pappu and Shrikant, 2004). Each T cell subset expresses a specific
set of glycan-modifying enzymes that regulate the pattern of
sialylation on the cell surface (Bi and Baum, 2009). Besides
being able to sialylate mucin-like molecules expressed on the
parasite surface, Tc-TS is also capable of re-sialylating host cell
asialoglycoconjugates (Mucci et al., 2006). Regarding T cells,
such event is able to modulate both their function and half-
life. Several papers published elsewhere have demonstrated that
alterations in Sia residues on thymocytes and mature T cells
are able to induce apoptosis (Leguizamon et al., 1999; Mucci
et al., 2002, 2005, 2006). Given the way TS works, it comes as
a logical conclusion that the parasite’s ability to modulate the T
cell sialophenotype is a powerful tool in evading detection and
elimination by the host immune system. Pioneering studies on
the impact of Tc-TS on T cells (Chuenkova and Pereira, 1995)
demonstrated that intravenous injection of minute amounts
of native Tc-TS was able to increase the parasitemia and
mortality of T. cruzi-infected mice. The authors suggested that
such effects were entirely dependent on Tc-TS activity, since
the same events did not occur in mice primed with viral or
bacterial sialidases. Further in vitro experiments demonstrated
that recombinant Tc-TS binds host T-lymphocytes, activating
CD4+ T cells through CD43 engagement (Todeschini et al.,
2002a,b). However, molecular evidences revealed that CD45
might be the main acceptor of Tc-TS during T. cruzi infection
(Muia et al., 2010). In vivo studies have highlighted the impact
of Tc-TS on B and T cells sialoglycophenotypes (Freire-de-
Lima et al., 2010; Bermejo et al., 2013), reinforcing the idea
that the Tc-TS may act as a virulence factor during T. cruzi
infection. In B cells, the sialylation of cell surface molecules
by Tc-TS elicits the production of IL-17. Interestingly, such
event triggers a signaling pathway that differs from the one
classically associated with IL-17, bypassing the activation of
RORγt and RORα (Bermejo et al., 2013). As for T cells, Freire-
de-Lima et al. (2010) demonstrated the relevance of Tc-TS on
the sialoglycophenotype of splenic CD8+ T cells during T. cruzi
infection. T. cruzi-infected or Plasmodium berghei-infected mice
were sacrificed on the eighth day post-infection (dpi), and
the sialoglycophenotype of CD8+ T cells was assessed. As
expected, CD8+ T cells from P. berghei-infected mice were highly
positive for PNA (PNAhigh). Interestingly, the glycophenotype
PNA intermediate (PNAint) exhibited by CD8+ T cells derived
from T. cruzi-infected mice, becomes PNAlow after intravenous
administration recombinant aTS. Such event was able to inhibit
the cytotoxic response mediated by antigen specific CD8+ T
cells, supporting the idea that re-sialylation of asialoglycans on
the surface of activated T cells might be a sophisticated evasion
mechanism adopted by T. cruzi to subvert the host immune
response (Freire-de-Lima et al., 2010). In addition, we found
that CD8+ T cells from T. cruzi-infected mice primed with
recombinant iTS exhibited a glycophenotype PNAhigh, suggesting
that iTS might have been able to compete with the native
aTS by serum sialoglycoproteins, compromising the expected
event of re-sialylation that takes place during the acute phase
of Chagas disease (Freire-de-Lima et al., 2010). Although the
evidence is quite compelling, new experiments with ST3 Gal-
I KO mice must be conducted in order to understand the
effects triggered by Tc-Ts on CD8+ T cells during T. cruzi
infection. Several immunobiological effects mediated by Tc-TS
have been described elsewhere (Mucci et al., 2006; Ruiz Díaz
et al., 2015), but the chemical evidence of the enzyme’s essential
role in the parasite is still lacking due to the absence of specific
inhibitors of Tc-TS. As it stands Tc-TS is a promising target
in drug design, an area in which further research is urgently
needed.
CONCLUSION
Over the last years, several papers have demonstrated the
importance of differential sialylation for CD8+ T cells with
respect to their maturation (Moody et al., 2001; Naito-Matsui
et al., 2014), activation (Pappu and Shrikant, 2004), and cytotoxic
responses (Sadighi Akha et al., 2006). However, few studies
provided insights into the impact of surface sialylation of CD8+
T cells on infectious diseases. Infection with T. cruzi is of
particular interest in this context because the parasite releases
into the host plasma large amounts of proteins belonging to
the TS family (Frasch, 1994; Schenkman et al., 1994; Giorgi
and de Lederkremer, 2011; Freire-de-Lima et al., 2012, 2015).
Recent studies demonstrated that cell surface asialoglycans on B
and T lymphocytes might be sialylated by the action of Tc-TS
(Freire-de-Lima et al., 2010; Bermejo et al., 2013). Such events
were able to disturb the host immune response and allow for
the continuation of the parasite in the infected host. Since it is
universally accepted that Tc-TS acts as a virulence factor during
T. cruzi infection, further efforts are needed in this lively area
to better understand the catalytic mechanism, as well as the
functional properties of the Sia-dependent enzyme. Certainly,
new impacting findings will contribute to further research on
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the enzyme as a therapeutic target in the fight against Chagas’
disease.
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